Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

447 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy Trial.
Saag KG, Pannacciulli N, Geusens P, Adachi JD, Messina OD, Morales-Torres J, Emkey R, Butler PW, Yin X, Lems WF. Saag KG, et al. Among authors: lems wf. Arthritis Rheumatol. 2019 Jul;71(7):1174-1184. doi: 10.1002/art.40874. Epub 2019 May 25. Arthritis Rheumatol. 2019. PMID: 30816640 Free PMC article. Clinical Trial.
Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial.
de Jong Z, Munneke M, Lems WF, Zwinderman AH, Kroon HM, Pauwels EK, Jansen A, Ronday KH, Dijkmans BA, Breedveld FC, Vliet Vlieland TP, Hazes JM. de Jong Z, et al. Among authors: lems wf. Arthritis Rheum. 2004 Apr;50(4):1066-76. doi: 10.1002/art.20117. Arthritis Rheum. 2004. PMID: 15077288 Free article. Clinical Trial.
Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.
Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA. Lems WF, et al. Osteoporos Int. 2006;17(5):716-23. doi: 10.1007/s00198-005-0037-2. Epub 2006 Feb 3. Osteoporos Int. 2006. PMID: 16463007 Clinical Trial.
Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
de Nijs RN, Jacobs JW, Lems WF, Laan RF, Algra A, Huisman AM, Buskens E, de Laet CE, Oostveen AC, Geusens PP, Bruyn GA, Dijkmans BA, Bijlsma JW; STOP Investigators. de Nijs RN, et al. Among authors: lems wf. N Engl J Med. 2006 Aug 17;355(7):675-84. doi: 10.1056/NEJMoa053569. N Engl J Med. 2006. PMID: 16914703 Free article. Clinical Trial.
Review and evaluation of the Dutch guidelines for osteoporosis.
Geusens PP, Lems WF, Verhaar HJ, Leusink G, Goemaere S, Zmierczack H, Compston J. Geusens PP, et al. Among authors: lems wf. J Eval Clin Pract. 2006 Oct;12(5):539-48. doi: 10.1111/j.1365-2753.2006.00647.x. J Eval Clin Pract. 2006. PMID: 16987116 Review.
Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
Jacobs JW, de Nijs RN, Lems WF, Geusens PP, Laan RF, Huisman AM, Algra A, Buskens E, Hofbauer LC, Oostveen AC, Bruyn GA, Dijkmans BA, Bijlsma JW. Jacobs JW, et al. Among authors: lems wf. J Rheumatol. 2007 May;34(5):1051-7. Epub 2007 Apr 1. J Rheumatol. 2007. PMID: 17407214 Clinical Trial.
447 results